Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data.
about
Pulmonary rehabilitation for chronic obstructive pulmonary diseaseFactors associated with reporting multiple causes of deathSix-minute walk distance in patients with severe end-stage COPD: association with survival after inpatient pulmonary rehabilitationHigher Lipoprotein (a) Levels Are Associated with Better Pulmonary Function in Community-Dwelling Older People - Data from the Berlin Aging Study II.Chronic airway disease: the infection connection.Recent changes: pulmonary medicine.Preclinical vascular disease identifies smokers at risk for COPD.Human endothelial progenitor cells isolated from COPD patients are dysfunctional.Pulmonary rehabilitation for chronic obstructive pulmonary disease.Recent trends in physician diagnosed COPD in women and men in the UK.Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.Accuracy of death certificates in COPD: analysis from the TORCH trial.Mortality in COPD: inevitable or preventable? Insights from the cardiovascular arena.Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi.Changing the burden of COPD mortalityComorbidities in chronic obstructive pulmonary disease.Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD.COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.Do we need new antibiotics for treating exacerbations of COPD?Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.Lung disease mortality in the United States: the National Longitudinal Mortality StudyPreventive Role of Tetraspanin CD9 in Systemic Inflammation of Chronic Obstructive Pulmonary Disease.Chronic Obstructive Pulmonary Disease and its Non-Smoking Risk Factors in India.Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis.Prevalence of chronic obstructive pulmonary disease and rhinitis in northern Greece.The evaluation of general practitioners' awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburb.COPD-Related Mortality and Co-morbidities in Northeastern Italy, 2008-2012: A Multiple Causes of Death Analysis.Lies, damned lies and mortality statistics?End-of-life care for patients with COPD in the community setting.Acute exacerbation of COPD requiring admission to the intensive care unit.Deaths with asthma in France, 2000-2005: a multiple-cause analysis.Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.The role of the β2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients.A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001.Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment.Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.Palliative care in chronic obstructive pulmonary disease: a review for clinicians.Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease.A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies.Medicaid expansion and chronic obstructive pulmonary disease among low-income adults in the United States.
P2860
Q24243959-CEE11396-625A-442C-9C16-B6FA459D1D47Q24803041-DFEB3F52-D22B-4873-9560-3E57A7826F2DQ30433001-0CFF507E-CBF2-4782-A48D-4DA247053E40Q30999453-BBD5AA6C-1C6B-4678-B76E-9214056345D2Q33644972-F8CA02C9-7590-4D8B-B90E-00E41D78B511Q33793338-CDF90C11-AB30-4136-9864-480C3E533A4DQ33928645-AC48DB69-75B6-49BF-A321-51F7D0AFFE34Q34090416-5B60D0DF-615E-4629-8158-AC984BBECFA4Q34140895-77719EE5-7DF4-4719-8F7F-CA93990D7FCFQ35534024-9D12B93D-6860-4D7D-ADB6-470F75684FC3Q36237989-A2F810C8-DF17-4ED9-AA90-52411C804023Q36715359-C4A5075B-8595-440C-BB5F-50FC78896DE8Q36742804-016C68EE-5EEC-4E95-BED1-9DA80BA9EE11Q36950185-7B7CE850-D3CD-46E9-AB9D-C2181BDD6F0EQ37018812-F9B40A48-C34B-4566-8D61-4B30CC7085CEQ37103715-2168D027-A0B6-4A79-A7E5-16C725C60366Q37217701-B8FA9ABA-3C8A-4477-BE0F-8A05305858AEQ37231865-3D14FF53-E85B-4C03-9748-8D4691567CF1Q37362577-DFE83579-9F34-4C16-82C9-16571911766BQ37367648-63B56B59-0EA2-4E86-B3FD-8BCCD4519DB1Q37396469-F4F4BBC8-AA62-433F-8C67-1E061279923AQ38588362-1D83BD34-8E33-4356-BECF-A5EEE1EFE7AFQ38603104-052336A9-CFAE-4640-BC08-9B469A9A435FQ38794102-75AC535D-8564-4F18-9018-F631D935B4E8Q39719623-A4AB2258-BFF3-4348-B22E-24F4B5236D76Q40093103-4131ECA0-5E9F-47CF-8590-2C98C9D0FA99Q41363781-0EB38C44-B060-4361-8C37-E783B55972F9Q42773565-ED6E9158-35EC-4DD0-9202-F87E5A89181FQ43256112-121328BB-E366-4AB7-BE81-16B19765544FQ44128265-A20F4813-22CE-4264-9650-E630DA50984FQ45899620-462E7AB5-02E8-4CC1-8BAB-34B689A36B36Q46057464-3EC55CCE-53EB-462F-AC96-AD1AAC4D88A8Q46123615-6B948F7C-FFBC-438F-AE56-413C39DA2B00Q47682702-72D5CA85-A257-4E86-AA18-ABBE2F7D0FA8Q47755387-7FA0D917-1AEE-438A-B787-978FFC7653D4Q48611059-53F1502F-08BC-4A5F-8438-B08171C2CDCCQ50803732-7FF19567-EF06-490A-98ED-780D78307703Q50867469-82746355-DB09-4C78-A8B4-945DE2B535FAQ51137433-84EE2864-E945-4C41-ADDD-2294A263AE7BQ51348468-8B0C179D-537B-4DB2-B86F-C9F3816BFC83
P2860
Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Obstructive lung disease death ...... multiple-cause mortality data.
@en
type
label
Obstructive lung disease death ...... multiple-cause mortality data.
@en
prefLabel
Obstructive lung disease death ...... multiple-cause mortality data.
@en
P2093
P2860
P1476
Obstructive lung disease death ...... multiple-cause mortality data.
@en
P2093
P2860
P304
P356
10.1164/AJRCCM.156.3.9702026
P407
P433
P577
1997-09-01T00:00:00Z